top of page
Search


ReNerve Limited (ASX: RNV) — Transforming Nerve Repair Through Science - A Medical Tech Story.
ReNerve Limited (ASX: RNV) listed on the ASX in July 2023, positioning itself as a commercial-stage medtech company aiming to transform nerve repair through innovative tissue-engineered solutions. Less than two years later, the company has demonstrated consistent momentum in bringing its products to market, establishing international distribution networks, and expanding its product pipeline.

Noel Ong
Jun 257 min read


Fulcrum Lithium Limited (ASX: FUL) – Advancing Lithium Discovery in Nevada’s Lithium Belt.
Fulcrum Lithium Ltd (ASX: FUL) has entered the ASX stage with ambitions as large as its Nevada lithium portfolio. Since its IPO in November 2024, Fulcrum has maintained a sharp operational pace, demonstrating early exploration success and strategic clarity across three key lithium projects—Alkali Flats, Fairway, and Summit

Noel Ong
Jun 256 min read


WAM Income Maximiser Limited (ASX: WMX) – IPO Analysis on a Listed Investment Company - A Lower Risk Income Presevation Strategy.
A rare opportunity for investors seeking a consistent stream of franked monthly income, coupled with capital preservation and long-term growth.

Noel Ong
Jun 247 min read


Light, Healing, and Precision – Invion’s Path to Reinventing Skin Cancer Treatment
When it comes to transforming cancer care, true innovation lies not just in killing the cancer, but in seeing it and feeling it less, and healing with more grace. In this quiet revolution, Invion Limited (ASX: IVX) is emerging as a serious contender.

Noel Ong
Jun 236 min read


A Billion-Year Revelation in Iron Ore Genesis – Rewriting the Hamersley Legacy - Is There A Hidden Source of Iron Ore Waiting To Be Discovered?
As an exploration geologist, the Hamersley iron story has always fascinated me. For decades, we’ve treated the timeline of iron ore formation in the Pilbara’s Hamersley Province as almost gospel. We referenced phosphate dating and clast-bearing conglomerates as reliable benchmarks. But what happens when new geochronological tools rip apart that foundation?

Noel Ong
Jun 227 min read


Rumble’s High-Grade Gold and Tungsten Put Western Queen in the Spotlight
Is Rumble Resources Limtied (ASX: RTR) a gold story that should be promoting itself more as a tungsten critical mineral conversation. As the tungsten narrative makes it move to be the king of the critical mienral list, one need to consider this story like the Delta Lithium (previusly Red Dirt Metals Limited (ASX:RDT) story when it was a gold project with an increadibly good lithium future.

Noel Ong
Jun 206 min read


99.5% Lithium Carbonate – A Clear Signal from Pursuit Minerals (ASX: PUR)
When Pursuit Minerals (ASX: PUR) announced it had dispatched 99.5% pure lithium carbonate samples to potential offtake and strategic partners, it caught my attention for all the right reasons. In a climate where investors are becoming more selective and market conditions remain tight, real progress—not marketing noise—matters.

Noel Ong
Jun 196 min read


Samso AI Radar - Weekly Review
If you're an investor in the Australian Stock Market, you may be curious about technology's growing impact on traditional industries. Artificial intelligence (AI) is revolutionizing how businesses operate and how investors assess potential returns. My learning curve in the space of AI is now my favourite topic of conversation. In the space of a month, my curiosity about this business has evolved from a casual conversation to one that is generating a passion for the business.

Noel Ong
Jun 188 min read


SuperAI 2025 Singapore – The Pulse of Global AI Innovation
SINGAPORE, 18 June 2025 – The Marina Bay Sands has transformed into the epicentre of artificial intelligence innovation as SuperAI 2025 goes live. With over 7,000 attendees, 1,000+ AI companies from 100+ countries, and a sold-out floor of 150+ exhibitors, this year’s edition is not just an event – it’s a signal. A signal that Asia’s role in shaping the AI future is not coming – it’s here.

Noel Ong
Jun 185 min read


FDA Clears First Blood Test for Diagnosing Alzheimer’s Disease: A New Era of Accessible, Early Detection for Dementia.
On 16 May 2025, the FDA cleared the first blood-based test for diagnosing Alzheimer’s disease—a major shift in how we detect the condition. Developed by Fujirebio Diagnostics, the Lumipulse test offers a simpler, faster, and less invasive alternative to PET scans and spinal taps, bringing early detection within easier reach for patients showing signs of cognitive decline.Â

Noel Ong
Jun 178 min read


Hooked on Whaleshark: Miramar’s New IOCG Targets Signal a Game-Changer. A Copper-Gold Monster?
As someone who’s followed Miramar Resources (ASX: M2R) since its IPO, I’ve always been intrigued by the Whaleshark Project. Located about 40km east of Onslow in Western Australia’s Ashburton region, this project has been on my radar due to its promising geology. But the recent announcement has taken my interest to a whole new level.

Noel Ong
Jun 165 min read


Navigating the ASX Mineral Exploration Landscape: Insights on Investing in the Small-Cap ASX Mineral Exploration Sector
Investing in mineral exploration stocks on the ASX can offer exciting opportunities, but it also carries unique challenges. With over 30 years of experience as a geologist in the industry, I have witnessed both the highs and lows of the mineral resource market. I have seen proejcts go from a Urnaium project to being a Phosphate project in 6 months and Nickel to Gold or vice versa, in a simialr time frame.
Knowing the complexities in this sector is vital for making informed i

Noel Ong
Jun 157 min read
bottom of page
